ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

July 26, 1985

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989